An excerpt from The Australian column dated 24 April...
[email protected]
McNamee believes this is the first time in Australia's history that we have made a significant global medical breakthrough and then participated in the final commercial rewards. Conservatively - and initially - it is likely to add between $150 million and $200 million to CSL profits in two or three years or about $1 a share (after tax) at the high end. But it could be much bigger because the CSL technology, which is based on the amazing work of Ian Frazer and the University of Queensland, has enabled CSL to also gain a royalty interest in a rival GlaxoSmithKline product. The CSL equity in the blockbuster drugs is now worth at the very least $2 billion.
- Forums
- ASX - By Stock
- CSL
- buy buy buy buy buy -
buy buy buy buy buy - , page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$299.31 |
Change
3.530(1.19%) |
Mkt cap ! $144.9B |
Open | High | Low | Value | Volume |
$296.29 | $299.39 | $296.14 | $121.1M | 405.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29 | $299.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$299.34 | 41 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29 | 299.000 |
1 | 200 | 298.500 |
1 | 1256 | 298.270 |
1 | 1256 | 298.100 |
1 | 74 | 298.030 |
Price($) | Vol. | No. |
---|---|---|
299.340 | 41 | 1 |
299.370 | 31 | 1 |
299.390 | 20 | 1 |
299.400 | 2000 | 1 |
299.440 | 1256 | 2 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online